Literature DB >> 31930494

Impact of atopic dermatitis on quality of life in adults: a systematic review and meta-analysis.

Gurkiran Birdi1, Richard Cooke1, Rebecca C Knibb1.   

Abstract

Atopic dermatitis (AD) can affect quality of life (QoL) of adult patients in whom the condition can be severe and persistent. There are currently no systematic reviews of the impact of AD on adults. This paper provides the first systematic literature review and meta-analysis of the impact of AD on QoL in adults. A systematic search was conducted using MEDLINE, Scopus, and Web of Science for articles published until October 2018. Inclusion criteria were a clinical diagnosis of AD, adult patients, and QoL as an outcome measure. Interventions were excluded. A total of 32 studies were included. While QoL was assessed using Dermatology Life Quality Index (DLQI) in 25 studies, there was heterogeneity in the tools used to measure disease severity across studies. Meta-analysis of the seven studies that used the SCORAD to measure disease severity showed severity to be significantly related to poorer QoL. The remaining 18 studies also showed increased disease severity significantly related to poorer QoL. When compared to healthy controls, AD patients demonstrated significantly lower QoL, but findings were mixed in studies that compared QoL in AD to other skin conditions. The findings highlight the significant impact that AD has on QoL in adults and the need for validated and relevant QoL measures to be implemented in clinical assessments for AD. Areas that require further research include an exploration of gender differences in QoL and the use of longitudinal study designs to explore factors that may cause differences in QoL ratings.
© 2020 The International Society of Dermatology.

Entities:  

Mesh:

Year:  2020        PMID: 31930494     DOI: 10.1111/ijd.14763

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  9 in total

1.  Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis.

Authors:  Kamilla Koszorú; Krisztina Hajdu; Valentin Brodszky; Alex Bató; L Hunor Gergely; Anikó Kovács; Zsuzsanna Beretzky; Miklós Sárdy; Andrea Szegedi; Fanni Rencz
Journal:  Eur J Health Econ       Date:  2022-04-12

2.  Factors Associated with Affective Symptoms and Quality of Life in Patients with Atopic Dermatitis.

Authors:  Silvia Mariel Ferrucci; Simona Tavecchio; Luisa Angileri; Teresa Surace; Emilio Berti; Massimiliano Buoli
Journal:  Acta Derm Venereol       Date:  2021-11-10       Impact factor: 3.875

3.  Baseline Demographics and Severity and Burden of Atopic Dermatitis in Adult Patients Initiating Dupilumab Treatment in a Real-World Registry (PROSE).

Authors:  Jerry Bagel; Tien Q Nguyen; Hermenio Lima; Neal Jain; David M Pariser; Sylvia Hsu; Gil Yosipovitch; Haixin Zhang; Jingdong Chao; Shikha Bansal; Zhen Chen; Daniel Richman; Andrew Korotzer; Marius Ardeleanu
Journal:  Dermatol Ther (Heidelb)       Date:  2022-05-20

Review 4.  Atopic dermatitis: an expanding therapeutic pipeline for a complex disease.

Authors:  Thomas Bieber
Journal:  Nat Rev Drug Discov       Date:  2021-08-20       Impact factor: 84.694

5.  Risk of Venous Thromboembolism Among Patients with Atopic Dermatitis: A Cohort Study in a US Administrative Claims Database.

Authors:  Kristin J Meyers; Jonathan I Silverberg; Maria Jose Rueda; Robert Goodloe; Evangeline J Pierce; Walter Deberdt; Dennis R Brinker
Journal:  Dermatol Ther (Heidelb)       Date:  2021-04-30

6.  Possible role of arginase 1 positive microglia on depressive/anxiety-like behaviors in atopic dermatitis mouse model.

Authors:  Bohyun Yang; Jae-Sang Ryu; Chan Rim; Jung U Shin; Min-Soo Kwon
Journal:  Arch Pharm Res       Date:  2022-01-20       Impact factor: 4.946

7.  Impact of the COVID-19 Pandemic on Atopic Dermatitis Patients.

Authors:  Joanna Sieniawska; Aleksandra Lesiak; Karol Ciążyński; Joanna Narbutt; Magdalena Ciążyńska
Journal:  Int J Environ Res Public Health       Date:  2022-02-02       Impact factor: 3.390

Review 8.  Human Tissue Kallikreins-Related Peptidases Are Targets for the Treatment of Skin Desquamation Diseases.

Authors:  Marcelo B Zani; Aquiles M Sant'Ana; Rafael C Tognato; Jair R Chagas; Luciano Puzer
Journal:  Front Med (Lausanne)       Date:  2022-03-04

9.  National Information Campaign Revealed Disease Characteristic and Burden in Adult Patients Suffering from Atopic Dermatitis.

Authors:  Niccolò Gori; Andrea Chiricozzi; Franco Marsili; Silvia Mariel Ferrucci; Paolo Amerio; Vincenzo Battarra; Salvatore Campitiello; Antonio Castelli; Maurizio Congedo; Monica Corazza; Antonio Cristaudo; Gabriella Fabbrocini; Giampiero Girolomoni; Giovanna Malara; Giuseppe Micali; Giovanni Palazzo; Aurora Parodi; Annalisa Patrizi; Giovanni Pellacani; Paolo Pigatto; Eugenio Provenzano; Pietro Quaglino; Marco Romanelli; Mariateresa Rossi; Paola Savoia; Ketty Peris
Journal:  J Clin Med       Date:  2022-09-02       Impact factor: 4.964

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.